WKN: | A1W1SJ |
ISIN: | US29664W1053 |
Land: | USA |
Branche: | Chemie, Pharma, Bio- & Medizintechnik |
Sektor: | Biotechnologie |
Weshalb die Esperion Therapeutics-Aktie
ein D-Rating hat,
erfahren Sie im Performance-Check
vom 09. September 2025 Info.
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2017 | 11,69 | 54,71 | 368,01% |
2 | 2019 | 37,58 | 52,38 | 39,38% |
3 | 2022 | 4,18 | 5,42 | 29,67% |
4 | 2025 | 2,12 | 2,11 | -0,47% |
5 | 2024 | 2,69 | 2,12 | -21,19% |
6 | 2015 | 28,96 | 20,22 | -30,18% |
7 | 2018 | 54,71 | 37,58 | -31,31% |
8 | 2016 | 20,22 | 11,69 | -42,19% |
9 | 2023 | 5,42 | 2,69 | -50,37% |
10 | 2020 | 52,38 | 21,86 | -58,27% |
11 | 2021 | 21,86 | 4,18 | -80,88% |
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2021 | 21,86 | 4,18 | -80,88% |
2 | 2020 | 52,38 | 21,86 | -58,27% |
3 | 2023 | 5,42 | 2,69 | -50,37% |
4 | 2016 | 20,22 | 11,69 | -42,19% |
5 | 2018 | 54,71 | 37,58 | -31,31% |
6 | 2015 | 28,96 | 20,22 | -30,18% |
7 | 2024 | 2,69 | 2,12 | -21,19% |
8 | 2025 | 2,12 | 2,11 | -0,47% |
9 | 2022 | 4,18 | 5,42 | 29,67% |
10 | 2019 | 37,58 | 52,38 | 39,38% |
11 | 2017 | 11,69 | 54,71 | 368,01% |